Last reviewed · How we verify
YYD601 2
At a glance
| Generic name | YYD601 2 |
|---|---|
| Sponsor | Yooyoung Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1) (PHASE1)
- Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients (PHASE3)
- Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD) (PHASE3)
- PK/PD Clinical Trial of YYD601 in Healthy Adult Male (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YYD601 2 CI brief — competitive landscape report
- YYD601 2 updates RSS · CI watch RSS
- Yooyoung Pharmaceutical Co., Ltd. portfolio CI